- $74.15m
- $48.76m
- $6.02m
Brief: Helius Medical Technologies, Inc. Announces Issuance Of U.S. Patent For Wireless Pons®
U.S. RESEARCH ROUNDUP-Coresite Realty, Hanmi Financial, Y-Mabs Therapeutics
Brief: Helius Medical Technologies Posts Q3 Loss Per Share Of $2.01
Helius Medical sinks on deep-discounted share offering
Brief: Helius Medical Technologies Announces Pricing Of $9.6 Million Underwritten Public Offering Of Common Stock
Brief: Helius Medical Technologies Announces Proposed Underwritten Public Offering Of Common Stock
Brief: Helius Medical Technologies Inc Receives PoNS Market Authorization In Australia
Brief: Helius Medical Technologies Appoints Paul Buckman To Board Of Directors
Brief: Helius Medical Technologies Entered Agreements With Lincoln Park Capital Fund
Brief: Helius Medical Technologies, Inc. Announces Voluntary De-Listing From Toronto Stock Exchange
U.S. STOCKS ON THE MOVE-Tesla, Helius Medical Tech, General Motors, Lightning eMotors
Helius Medical Tech jumps on FDA's breakthrough designation for balance device
Brief: Helius Medical Technologies Announces FDA Breakthrough Device Designation
Brief: Helius Medical Technologies Reports Q2 Loss Per Share Of $2.58
Brief: Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt As Chief Medical Officer
Brief: Helius Medical Technologies, Inc. Expands Executive Leadership Team With The Appointment Of Dane C. Andreeff As President And Chief Executive Officer And Jeffrey S. Mathiesen As Chief Financial Officer
Brief: Helius Medical Reports Q1 Loss Per Share Of $1.65
Brief: Helius Medical, Inc Receives U.S. Marketing Authorization For The Pons™ Device
Brief: FDA Authorizes Marketing Of Device To Improve Gait In Multiple Sclerosis Patients